John B. Landis - 05 Jan 2024 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Issuer symbol
EYPT
Transactions as of
05 Jan 2024
Net transactions value
$0
Form type
4
Filing time
09 Jan 2024, 20:55:24 UTC
Previous filing
22 Jun 2023
Next filing
07 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Restricted Stock Units Award $0 +10,000 $0.000000 10,000 05 Jan 2024 Common Stock 10,000 $0.000000 Direct
transaction EYPT Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 05 Jan 2024 Common Stock 20,000 $20.40 Direct
transaction EYPT Stock Option (Right to Buy) Award $0 +25,014 $0.000000 25,014 05 Jan 2024 Common Stock 25,014 $20.40 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.